These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7940821

  • 1. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G, Tarantino A, Aroldi A, Banfi G, Cesana B, Ponticelli C.
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract] [Full Text] [Related]

  • 2. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N, Ohmori Y, Tsuji T, Oka T.
    Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract] [Full Text] [Related]

  • 3. Dislipidemia at different immunosuppressive protocols.
    Zezina L, Rosental R.
    Transplant Proc; 1994 Dec; 26(6):3223. PubMed ID: 7998123
    [No Abstract] [Full Text] [Related]

  • 4. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K, Wójcicka-Bentyn J, Sieńko J, Grymowicz M, Smolarczyk R, Malinowska-Polubiec A, Romejko E.
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun 15; 114(2):155-61. PubMed ID: 15140508
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S, Garrigue V, Dupuy AM, Chong G, Cristol JP, Mourad G.
    Transplant Proc; 2006 Sep 15; 38(7):2314-6. PubMed ID: 16980076
    [Abstract] [Full Text] [Related]

  • 10. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
    Hohage H, Arlt M, Brückner D, Dietl KH, Zidek W, Spieker C.
    Clin Transplant; 1997 Jun 15; 11(3):225-30. PubMed ID: 9193847
    [Abstract] [Full Text] [Related]

  • 11. Tubular effects of cyclosporine in pediatric renal transplant recipients.
    Laine J, Holmberg C.
    Transplant Proc; 1996 Aug 15; 28(4):2104-6. PubMed ID: 8769167
    [No Abstract] [Full Text] [Related]

  • 12. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
    Bakar F, Keven K, Dogru B, Aktan F, Erturk S, Tuzuner A, Erbay B, Nebioglu S.
    Transplant Proc; 2009 Jun 15; 41(5):1630-3. PubMed ID: 19545695
    [Abstract] [Full Text] [Related]

  • 13. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
    Süleymanlar G, Ozben T, Sapan M, Yìlmaz H, Yakupoglu G, Karpuzoglu T.
    Transplant Proc; 1994 Oct 15; 26(5):2637-8. PubMed ID: 7940822
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience.
    Manu M, Tanabe K, Tokumoto T, Ishikawa N, Shimizu T, Okuda H, Ito S, Shimmura H, Inui M, Harano M, Shiroyanagi Y, Yagisawa T, Fuchinoue S, Toma H.
    Transplant Proc; 2000 Nov 15; 32(7):1736-8. PubMed ID: 11119912
    [No Abstract] [Full Text] [Related]

  • 16. Conversion of cyclosporine to azathroprine in renal transplant recipients.
    Bassiri A, Amiranssari B, Gol S.
    Transplant Proc; 1995 Oct 15; 27(5):2691. PubMed ID: 7482877
    [No Abstract] [Full Text] [Related]

  • 17. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
    Buchholz B, Korn A.
    Transplant Proc; 1996 Aug 15; 28(4):2187-8. PubMed ID: 8769195
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
    Jurewicz WA.
    Transplant Proc; 1999 Nov 15; 31(7A):64S-66S. PubMed ID: 10576048
    [No Abstract] [Full Text] [Related]

  • 20. Hyperlipidemia in stable renal transplant recipients.
    Ong-Ajyooth L, Sirisalee K, Shayakul C, Vareesangthip K, Vasuvattakul S, Chirawong P, Vanichakarn S, Nimmannit S, Ong-Ajyooth S, Nilwarangkur S.
    Transplant Proc; 1994 Aug 15; 26(4):2062-4. PubMed ID: 8066670
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.